Glucosum Et Natrium Chloratum 1:1 Fresenius (Sodium Chloride, Glucose Monohydrate)

Glucosum Et Natrium Chloratum 1:1 Fresenius is used in clinical settings to restore fluid balance and provide an energy source when oral intake is insufficient.

• Replacement of extracellular fluid losses due to surgery, trauma, or burns.
• Correction of hyponatremia or other electrolyte disturbances.
• Support of parenteral nutrition regimens by supplying glucose.
• Maintenance of intravascular volume during diagnostic or therapeutic procedures.
• Adjunctive therapy in patients receiving other intravenous medications that may cause electrolyte shifts.

Adverse reactions to Glucosum Et Natrium Chloratum 1:1 Fresenius are generally related to the infusion itself or the individual components.

Common

• Mild infusion site irritation or erythema.
• Transient hyperglycemia, especially in patients with impaired glucose tolerance.
• Slight increase in serum sodium levels.
• Fluid overload manifested as peripheral edema.

Serious

• Severe hypernatremia leading to neurologic symptoms.
• Anaphylactoid reactions such as urticaria, bronchospasm, or hypotension.
• Metabolic acidosis in patients with compromised renal function.
• Pulmonary edema due to excessive volume administration.

When prescribing or administering Glucosum Et Natrium Chloratum 1:1 Fresenius, clinicians should observe several safety considerations.

• Verify patient’s electrolyte status and serum glucose before infusion.
• Adjust infusion rate in patients with heart failure or renal insufficiency to avoid fluid overload.
• Use aseptic technique to prevent contamination of the sterile solution.
• Monitor vital signs and laboratory values during and after administration.
• Avoid rapid bolus administration unless specifically indicated.
• Consider alternative formulations for patients with known hypersensitivity to sodium chloride or glucose.

Glucosum Et Natrium Chloratum 1:1 Fresenius may interact with other intravenous agents or systemic medications.

Avoid

• Concurrent high‑dose insulin therapy without glucose monitoring, which can precipitate hypoglycemia.
• Large volumes of other sodium‑containing solutions that may cause hypernatremia.
• Medications that increase the risk of fluid overload, such as certain chemotherapeutic agents.

Use with caution

• Diuretics, which may alter electrolyte balance and require closer monitoring.
• Corticosteroids, which can affect glucose metabolism.
• Vasopressors, as changes in intravascular volume may influence hemodynamic response.
• Renal replacement therapies, where electrolyte shifts are common.